Dr. Akhileshwar Namani

Dr. Akhileshwar Namani is working as a Scientist in the Department of Molecular Oncology at Sri Shankara Cancer Hospital and Research Centre (SSCHRC) and the Sri Shankara National Centre for Cancer Prevention and Research (SSNCCPR) in Bengaluru, India. Specializing in biomedical genomics, cancer bioinformatics, and multi-omics research, his work bridges computational biology with translational oncology. His research primarily focuses on deciphering the molecular mechanisms of cancer progression and therapeutic resistance, biomarker discovery, and drug discovery. Dr. Namani earned his Ph.D. in Biochemistry and Molecular Biology from Zhejiang University School of Medicine (THE world rank #47) in 2017, supported by a prestigious international scholarship from the China Scholarship Council. He later completed a two-year postdoctoral fellowship at the same institution before serving as an Assistant Professor in the Department of Biotechnology at GITAM University from 2020 to 2022.

Over his career, he has built a strong scholarly footprint with over 23 peer-reviewed publications in reputable peer reviewed high impact journals, accumulating more than 2,900 citations with an H-index of 13. He is the Principal Investigator and Co-Principal Investigator of major national research grants from agencies like the Indian Council of Medical Research (ICMR) and the Anusandhan National Research Foundation (ANRF). In addition to his research activities, Dr. Namani is serving on the editorial boards of Phenomics, BMC Cancer, Discover Oncology, and Discover Medicine (Springer Nature journals), acting as an expert reviewer of >30 journals, and frequently presenting as an invited speaker and key opinion leader at oncology and molecular pathology conclaves. He is an active member of leading global oncology societies, including the European Society for Medical Oncology and the International Association for the Study of Lung Cancer.2